On ‘Jobs That Pay’ Tour, Governor Wolf Visits Adaptimmune Therapeutics
July 24, 2017
Philadelphia, PA – Governor Wolf today toured Adaptimmune Therapeutics, a clinical stage biopharmaceutical company, and participated in a roundtable discussion with employees focused on expanding job creation and workforce training in the commonwealth.
“I am thrilled to see a company like Adaptiummune creating new, high-paying jobs, and thriving in Pennsylvania,” said Governor Wolf. “We need to continue to do what we can to help set the table for robust private sector growth. The important work being done at the company’s new headquarters and manufacturing site transcends state borders, and I’m proud to support Pennsylvania’s life science companies.”
Coordinated by the Governor’s Action Team, in October 2015, Adaptimmune announced its plans expand and create 110 new, high-paying jobs in Philadelphia. Today, the governor toured the company’s newly constructed, 47,400-square-foot U.S. headquarters and base for clinical and manufacturing operations at the Philadelphia Navy Yard.
“The Philadelphia Navy Yard is fast becoming a vibrant hub for biotechnology in the region, and at Adaptimmune we are very proud to be leaders in this space,” commented William Bertrand, Adaptimmune’s Chief Operating Officer. “We are committed to the Navy Yard, and we have confidence in Pennsylvania as a powerhouse for scientific and medical achievement. We were honored to host Governor Wolf today, and we thank him for his outstanding commitment to making Pennsylvania a great place to create new businesses and jobs.”
Founded in 2008, Adaptimmune is a clinical stage biopharmaceutical company focused on novel cancer immunotherapy products based on its T-cell receptor platform. Adaptimmune launched its U.S. operations in Philadelphia in 2011, operating out of the University City Science Center, Philadelphia.